In this visionary presentation, Dr. Nathan Bryan, founder and CEO of Bryan Therapeutics, shares how one tiny molecule — nitric oxide (NO) — could redefine modern medicine and the future of human longevity.
Dr. Bryan, a world-renowned biochemist and former Professor of Molecular Medicine at UT Medical School in Houston, explains how nitric oxide addresses the root cause of all age-related disease, from cardiovascular and metabolic dysfunction to Alzheimer’s and autoimmune disorders. He outlines how restoring nitric oxide levels improves blood flow, oxygenation, immune balance, and cellular repair, effectively targeting ischemia, inflammation, and oxidative stress — the shared hallmarks of chronic disease.
In this talk, Dr. Bryan also introduces Bryan Therapeutics, a cash-flow-positive biotech company pioneering solid-dose nitric oxide gas therapies. The company’s lead drug, a first-in-class orally disintegrating nitric oxide tablet, is entering Phase 3 clinical trials for ischemic heart disease with FDA guidance allowing a single 100-patient study to demonstrate efficacy. The company also has drug programs for Alzheimer’s disease and diabetic ulcers, and consumer products already in market under the N1O1 brand.
Listeners and investors alike will hear how Dr. Bryan’s decades of research and more than $1 billion in product revenues have positioned nitric oxide as a central focus in the longevity and cardiovascular space. This episode reveals not just the science behind nitric oxide’s medical promise — but the opportunity to participate in its global commercialization and life-changing potential.